DiaMedica Therapeutics Inc. Capital Expenditures
DiaMedica Therapeutics Inc. (DMAC) reported Capital Expenditures of $11.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-10
- DiaMedica Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $3.00K, a 50.00% decline year-over-year.
- DiaMedica Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $8.00K, a 33.33% decline year-over-year.
- DiaMedica Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $6.00K, a 14.29% decline year-over-year.
- DiaMedica Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $16.00K, a 77.78% increase year-over-year.
- DiaMedica Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $40.00K, a 60.00% increase from fiscal 2024.
- DiaMedica Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $25.00K, a 4.17% increase from fiscal 2023.
- DiaMedica Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $24.00K, a 70.37% decline from fiscal 2022.
- DiaMedica Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $81.00K, a 268.18% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $11.00K 10-Q · filed 2026-08-10 | $17.00K derived: sum of 3 quarters · filed 2026-08-10 | $33.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $8.00K 10-Q · filed 2026-05-06 | $14.00K derived: sum of 2 quarters · filed 2026-05-06 | $30.00K derived: sum of 3 quarters · filed 2026-05-06 | $36.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $22.00K derived: sum of 2 quarters · filed 2026-03-30 | $28.00K derived: sum of 3 quarters · filed 2026-08-10 | $40.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $22.00K derived: sum of 2 quarters · filed 2026-08-10 | $34.00K 10-Q · filed 2025-11-12 | $41.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $18.00K 10-Q · filed 2026-08-10 | $25.00K derived: sum of 3 quarters · filed 2026-08-10 | $34.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $12.00K 10-Q · filed 2026-05-06 | $19.00K derived: sum of 2 quarters · filed 2026-05-06 | $28.00K derived: sum of 3 quarters · filed 2026-05-06 | $28.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $16.00K derived: sum of 2 quarters · filed 2026-03-30 | $16.00K derived: sum of 3 quarters · filed 2026-03-30 | $25.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $9.00K derived: sum of 2 quarters · filed 2025-11-12 | $18.00K 10-Q · filed 2025-11-12 | $21.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $9.00K 10-Q · filed 2025-08-12 | $12.00K derived: sum of 3 quarters · filed 2025-08-12 | $22.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $9.00K 10-Q · filed 2025-05-13 | $12.00K derived: sum of 2 quarters · filed 2025-05-13 | $22.00K derived: sum of 3 quarters · filed 2025-05-13 | $26.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $13.00K derived: sum of 2 quarters · filed 2025-03-17 | $17.00K derived: sum of 3 quarters · filed 2025-03-17 | $24.00K 10-K · filed 2025-03-17 |
| 2023-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $14.00K derived: sum of 2 quarters · filed 2024-11-13 | $21.00K 10-Q · filed 2024-11-13 | $53.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $11.00K 10-Q · filed 2024-08-07 | $43.00K derived: sum of 3 quarters · filed 2024-08-07 | $86.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $7.00K 10-Q · filed 2024-05-08 | $39.00K derived: sum of 2 quarters · filed 2024-05-08 | $82.00K derived: sum of 3 quarters · filed 2024-05-08 | $88.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $75.00K derived: sum of 2 quarters · filed 2024-03-19 | $81.00K derived: sum of 3 quarters · filed 2024-03-19 | $81.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $49.00K derived: sum of 2 quarters · filed 2023-11-13 | $49.00K 10-Q · filed 2023-11-13 | $56.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $6.00K 10-Q · filed 2023-08-14 | $13.00K derived: sum of 3 quarters · filed 2023-08-14 | $15.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | $7.00K derived: sum of 2 quarters · filed 2023-05-15 | $9.00K derived: sum of 3 quarters · filed 2023-05-15 | $13.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $9.00K derived: sum of 2 quarters · filed 2023-03-28 | $13.00K derived: sum of 3 quarters · filed 2023-03-28 | $22.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $6.00K derived: sum of 2 quarters · filed 2022-11-09 | $15.00K 10-Q · filed 2022-11-09 | $60.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $13.00K 10-Q · filed 2022-08-11 | $58.00K derived: sum of 3 quarters · filed 2022-08-11 | $58.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $9.00K 10-Q · filed 2022-05-04 | $54.00K derived: sum of 2 quarters · filed 2022-05-04 | $54.00K derived: sum of 3 quarters · filed 2022-05-04 | $54.00K derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $45.00K derived: sum of 2 quarters · filed 2022-03-14 | $45.00K derived: sum of 3 quarters · filed 2022-03-14 | $47.00K 10-K · filed 2022-03-14 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $2.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $2.00K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $2.00K 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $2.00K 10-K · filed 2021-03-10 | |||
| 2018-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $8.00K derived: sum of 2 quarters · filed 2020-03-23 | $18.00K derived: sum of 3 quarters · filed 2020-03-23 | $50.00K 10-K · filed 2020-03-23 |
| 2018-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $31.00K derived: sum of 2 quarters · filed 2019-11-13 | $63.00K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $42.00K 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | $32.00K 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | $22.00K 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |